Inventor · disambiguated record
Mark G. Frattini
Also filed as: FRATTINI MARK · FRATTINI MARK G
8 granted patents·2 pending applications·39 citations·filing 2011–2024
86Inventor score
Files withSLOAN KETTERING INST CANCER RES5SLOAN-KETTERING INST FOR CANCER RES2CELGENE QUANTICEL RES INC1FRATTINI MARK G1LIN BIOSCIENCE INC1
Top patents by PatentIndex Score
10 records- 0194US11666550B2CDC7 kinase inhibitors and uses thereofSLOAN KETTERING INST CANCER RES·Filed 2021·Granted Jun 6, 2023·2 cites·19 claims
- 0292US9492427B2CDC7 kinase inhibitors and uses thereofSLOAN-KETTERING INST FOR CANCER RES·Filed 2015·Granted Nov 15, 2016·9 cites·8 claims
- 0391US11045446B2Cdc7 kinase inhibitors and uses thereofSLOAN KETTERING INST CANCER RES·Filed 2018·Granted Jun 29, 2021·3 cites·2 claims
- 0491US9782386B2CDC7 kinase inhibitors and uses thereofSLOAN-KETTERING INST FOR CANCER RES·Filed 2016·Granted Oct 10, 2017·8 cites·16 claims
- 0590US10123992B2CDC7 kinase inhibitors and uses thereofSLOAN KETTERING INST CANCER RES·Filed 2017·Granted Nov 13, 2018·6 cites·32 claims
- 0689US2024423951A1Cdc7 kinase inhibitors and uses thereofSLOAN KETTERING INST CANCER RES·Filed 2024·Application pending·0 cites
- 0787US9180105B2CDC7 kinase inhibitors and uses thereofFRATTINI MARK G·Filed 2011·Granted Nov 10, 2015·11 cites·23 claims
- 0886US12109189B2CDC7 kinase inhibitors and uses thereofSLOAN KETTERING INST CANCER RES·Filed 2023·Granted Oct 8, 2024·0 cites·18 claims
- 0966US2025090495A1CDC7 Inhibitor Combinational TherapyLIN BIOSCIENCE INC·Filed 2024·Application pending·0 cites
- 1046US12447171B2Azacitidine in combination with venetoclax, gilteritinib, midostaurin or other compounds for treating leukemia or myelodysplastic syndromeCELGENE QUANTICEL RES INC·Filed 2020·Granted Oct 21, 2025·0 cites·39 claims
Join the waitlist — get patent alerts
Get an alert when Mark G. Frattini files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →